[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 42, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 60, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Franco  Valle", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 673659, "exercisedValue": 0, "unexercisedValue": 687866}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 64, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 53, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.37, "open": 9.51, "dayLow": 8.77, "dayHigh": 9.6664, "regularMarketPreviousClose": 9.37, "regularMarketOpen": 9.51, "regularMarketDayLow": 8.77, "regularMarketDayHigh": 9.6664, "beta": -0.452, "forwardPE": -2.6666665, "volume": 1271138, "regularMarketVolume": 1271138, "averageVolume": 753742, "averageVolume10days": 877170, "averageDailyVolume10Day": 877170, "bid": 9.01, "ask": 9.1, "bidSize": 200, "askSize": 100, "marketCap": 327597856, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 22.74, "fiftyDayAverage": 9.42, "twoHundredDayAverage": 10.6987, "currency": "USD", "enterpriseValue": 249212736, "floatShares": 22455665, "sharesOutstanding": 36238700, "sharesShort": 8187322, "sharesShortPriorMonth": 7586478, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.2259, "heldPercentInsiders": 0.25014, "heldPercentInstitutions": 0.64911, "shortRatio": 8.43, "shortPercentOfFloat": 0.3679, "impliedSharesOutstanding": 36238700, "bookValue": 2.096, "priceToBook": 4.3129773, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -144008000, "trailingEps": -4.01, "forwardEps": -3.39, "enterpriseToEbitda": -1.666, "52WeekChange": -0.023758113, "SandP52WeekChange": 0.31214523, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -18000000, "currentPrice": 9.04, "targetHighPrice": 128.0, "targetLowPrice": 11.0, "targetMeanPrice": 46.88, "targetMedianPrice": 40.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 87952000, "totalCashPerShare": 2.427, "ebitda": -149624992, "totalDebt": 9567000, "quickRatio": 3.19, "currentRatio": 3.395, "debtToEquity": 12.593, "returnOnAssets": -0.56379, "returnOnEquity": -1.04511, "freeCashflow": -65435500, "operatingCashflow": -112727000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]